Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line
Abstract: The characterization of human microglia has been hampered by poor availability of human cell sources. However, microglia is involved in the physiopathology of multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, HIV dementia, retinal degenerative diseases, cancer, and many other conditions. Therefore, there is an important need to have experimental paradigms of human microglia characterized and usable to study the role of microglia in the different pathologies in which it is involved. In the present work, we carried out an extensive characterization of Immortalized Human Microglia—SV40 cell line (IMhu), marketed by Applied Biological Material. The functional response of IMhu to a large variety of stimuli was studied. In particular, we investigated morphology, mortality, and changes in the production of different cytokines and chemokines, both under basal conditions and after stimulation. Moreover, western blotting analysis was conducted on phospho-mTOR (Ser 2448) and downstream parameters, p-P70S6K and 4EBP1, in order to understand if IMhu can be used for evaluations of mTOR pathway. In conclusion, IMhu cells proved to be a useful experimental model to investigate the physiopathology of inflammatory disease that involved microglia cells, including pathological conditions that involved the mTOR pathway.
Share & Cite This Article
Chiavari, M.; Ciotti, G.M.P.; Navarra, P.; Lisi, L. Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line. Brain Sci. 2019, 9, 111.
Chiavari M, Ciotti GMP, Navarra P, Lisi L. Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line. Brain Sciences. 2019; 9(5):111.Chicago/Turabian Style
Chiavari, Marta; Ciotti, Gabriella Maria Pia; Navarra, Pierluigi; Lisi, Lucia. 2019. "Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line." Brain Sci. 9, no. 5: 111.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.